Novel Coronavirus (COVID-19)

To date, CDC received COVID-19 supplemental funding through three congressional acts:

  • Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (P.L. 116-123): P.L. 116-123 provided $2.2 billion to CDC to prevent, prepare for and respond to COVID-19 domestically and internationally.
  • Coronavirus Aid, Relief, and Economic Security (CARES) Act (P.L. 116-136): P.L. 116-136 provided CDC $4.3 billion and ATSDR $12.5 million to prevent, prepare for and respond to COVID-19 domestically and internationally.
  • Paycheck Protection Program and Health Care Enhancement Act (P.L. 116-139): P.L. 116-139 provided $1.0 billion to CDC transferred from the Public Health Social Services Emergency Fund (PHSSEF) to support surveillance, epidemiology, laboratory capacity expansion, contact tracing, public health data surveillance and analytics infrastructure modernization, disseminating information about testing, and workforce support necessary to expand and improve COVID–19 testing. In addition, $10.25 billion from the PHSSEF was awarded to health departments through the CDC Epidemiology and Laboratory Capacity program for testing and contact tracing.
  • Coronavirus Response and Relief Supplemental Appropriations Act, 2021 (P.L. 116-260):
    • P.L. 116-260 provided $8.75 billion to CDC to plan, prepare for, promote, distribute, administer, monitor, and track coronavirus vaccines to ensure broad-based distribution, access, and vaccine coverage. On behalf of HHS, $19.11 billion from the PHSSEF was awarded to health departments through the CDC Epidemiology and Laboratory Capacity program for testing and contact tracing.
Grants.gov logo
Page last reviewed: January 8, 2021